Arcus Biosciences Inc (RCUS) — Cash Flow Reinvestment Rate
Arcus Biosciences Inc (RCUS) has a Cash Flow Reinvestment Rate of 1.15x as of September 2024, reinvesting $30.00 Million (capex $1.00 Million plus investments $-29.00 Million) from operating cash flow of $26.00 Million. Explore RCUS capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Arcus Biosciences Inc Cash Flow Reinvestment Rate (2020–2022)
Historical reinvestment intensity for Arcus Biosciences Inc across 2 annual periods. Also explore RCUS total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Arcus Biosciences Inc (2020–2022)
Year-by-year capital reinvestment analysis for Arcus Biosciences Inc. For live market cap and broader valuation context, see how much is Arcus Biosciences Inc worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.96x | $419.00 Million | $438.00 Million | $6.00 Million | ▼ -75.5% |
| 2020 | 3.91x | $434.37 Million | $111.17 Million | $3.06 Million | — |